Gong Wenjie, Yang Shenjiu, Yang Xiumin, Guo Fang
Zhongshan Hospital Affiliated to Fudan University, Department of Hematology, Shanghai, China.
Zhangqiu People's Hospital, Jinan Sixth Municipal Hospital, Department of Pathology, Jinan, China.
Clinics (Sao Paulo). 2016 Jul;71(6):311-4. doi: 10.6061/clinics/2016(06)04.
To predict the American Joint Cancer Committee tumor-node-metastasis stage in patients with papillary thyroid carcinoma by evaluating the relationship between the preoperative neutrophil-to-lymphocyte ratio and the tumor-node-metastasis stage.
We retrospectively examined 161 patients with a diagnosis of papillary thyroid carcinoma. The Neutrophil-to-Lymphocyte Ratio was calculated according to the absolute neutrophil counts and absolute lymphocyte counts on routine blood tests obtained prior to surgery and patients with a Neutrophil-to-Lymphocyte Ratio of 2.0 or more were classified as the high NLR group, while those with a Neutrophil-to-Lymphocyte Ratio less than 2.0 were classified as the low Neutrophil-to-Lymphocyte Ratio group. Clinicopathological variables, which were stratified by the Neutrophil-to-Lymphocyte Ratio, were analyzed. A multivariate analysis was performed to determine factors that affect the Neutrophil-to-Lymphocyte Ratio. The association between the Neutrophil-to-Lymphocyte Ratio and the TNM stage in patients ≥45 years of age was analyzed using the Spearman rank correlation.
Various blood indices, including hemoglobin, platelet and thyroid-stimulating hormone levels in the two groups showed no significant differences. Lymph node metastasis, multifocality and tumor size exhibited significant differences in the two groups (p=0.000, p=0.000 and p=0.035, respectively). Correlation analysis indicated that a higher preoperative Neutrophil-to-Lymphocyte Ratio was observed in patients with lymph node metastasis, larger tumor size and multifocality (r=0.341, p=0.000; r=0.271, p=0.000; and r=0.182, p=0.010, respectively). For patients ≥45 years of age, the number of patients with an advanced TNM stage in the high NLR group was higher than that in the low Neutrophil-to-Lymphocyte Ratio group (p=0.013). A linear regression analysis showed that the preoperative Neutrophil-to-Lymphocyte Ratio was positively correlated with the American Joint Cancer Committee tumor-node-metastasis stage (rho=0.403, p=0.000).
The preoperative Neutrophil-to-Lymphocyte Ratio was closely related to the stage of papillary thyroid carcinoma. The increase in the preoperative Neutrophil-to-Lymphocyte Ratio contributed to the advanced tumor-node-metastasis stage of papillary thyroid carcinoma patients ≥45 years of age.
通过评估术前中性粒细胞与淋巴细胞比值(NLR)与甲状腺乳头状癌患者肿瘤-淋巴结-转移(TNM)分期之间的关系,预测美国癌症联合委员会(AJCC)的TNM分期。
我们回顾性研究了161例诊断为甲状腺乳头状癌的患者。根据术前常规血液检查中的中性粒细胞绝对计数和淋巴细胞绝对计数计算NLR,NLR为2.0或更高的患者被归类为高NLR组,而NLR小于2.0的患者被归类为低NLR组。分析按NLR分层的临床病理变量。进行多因素分析以确定影响NLR的因素。使用Spearman等级相关性分析年龄≥45岁患者的NLR与TNM分期之间的关联。
两组的各种血液指标,包括血红蛋白、血小板和促甲状腺激素水平,均无显著差异。两组在淋巴结转移、多灶性和肿瘤大小方面存在显著差异(分别为p = 0.000、p = 0.000和p = 0.035)。相关性分析表明,淋巴结转移、肿瘤较大和多灶性的患者术前NLR较高(分别为r = 0.341,p = 0.000;r = 0.271,p = 0.000;r = 0.182,p = 0.010)。对于年龄≥45岁的患者,高NLR组中TNM分期较晚的患者数量高于低NLR组(p = 0.013)。线性回归分析表明,术前NLR与AJCC的TNM分期呈正相关(rho = 0.403,p = 0.000)。
术前NLR与甲状腺乳头状癌的分期密切相关。术前NLR升高促成了年龄≥45岁的甲状腺乳头状癌患者TNM分期较晚。